GF
DGX icon

Gabelli Funds’s Quest Diagnostics DGX Stock Holding History

Gabelli Funds’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$403K Hold
1,900
– – ﹤0.01% 1093
2026
Q1 		$372K Buy
1,900
+200
+12% +$38.9K ﹤0.01% 1079
2025
Q4 		$295K Hold
1,700
– – ﹤0.01% 1115
2025
Q3 		$324K Buy
1,700
+100
+6% +$17.7K ﹤0.01% 1103
2025
Q2 		$287K Buy
+1,600
New +$278K ﹤0.01% 1096
2015
Q4 		– Sell
-25,000
Closed -$1.54M – 1148
2015
Q3 		$1.54M Hold
25,000
– – 0.01% 777
2015
Q2 		$1.81M Buy
+25,000
New +$1.85M 0.01% 784

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Gabelli Funds's DGX Position: Q2 2026 in Review

Gabelli Funds held its Quest Diagnostics (DGX) position steady in Q2 2026 at 1,900 shares worth $403K. The position accounts for ﹤0.01% of the portfolio, ranked #1093.

Gabelli Funds first reported a position in DGX in Q2 2015 and has held it in 7 quarters since. The position peaked at $1.81M in Q2 2015. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Gabelli Funds held 1,900 shares of Quest Diagnostics worth $403K as of Q2 2026.
  • Gabelli Funds left its Quest Diagnostics share count unchanged in Q2 2026.
  • Quest Diagnostics made up ﹤0.01% of Gabelli Funds's portfolio in Q2 2026, its #1093 holding.
  • Gabelli Funds first reported a position in Quest Diagnostics in Q2 2015 and has held it in 7 quarters since.
  • Gabelli Funds's Quest Diagnostics position peaked at $1.81M in Q2 2015.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Gabelli Funds's 13F filing for Q2 2026, filed 12 Aug 2026.